1. Home
  2. MTEX vs CLRB Comparison

MTEX vs CLRB Comparison

Compare MTEX & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

N/A

Current Price

$9.33

Market Cap

18.2M

Sector

Health Care

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$3.82

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEX
CLRB
Founded
1993
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
12.8M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
MTEX
CLRB
Price
$9.33
$3.82
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
4.2K
62.8K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$110,411,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.50
$2.71
52 Week High
$16.49
$44.70

Technical Indicators

Market Signals
Indicator
MTEX
CLRB
Relative Strength Index (RSI) 54.63 56.76
Support Level $9.15 $3.30
Resistance Level $9.68 $3.15
Average True Range (ATR) 0.34 0.29
MACD -0.04 0.14
Stochastic Oscillator 59.76 94.64

Price Performance

Historical Comparison
MTEX
CLRB

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: